moxalactam has been researched along with Innate Inflammatory Response in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avery, GS; Brogden, RN; Carmine, AA; Heel, RC; Romankiewicz, JA; Speight, TM | 1 |
Eron, LJ; Goldenberg, RI; Hixon, DL; Park, CH; Poretz, DM | 1 |
Bouza, E; Guerrero, A; Hospital, JS; Loza, E; Martínez-Beltrán, J; Pérez del Rio, J; Rodríguez-Creixems, M | 1 |
Hagiwara, S; Ide, M; Jimbo, M; Tanaka, N; Umebara, Y; Yamamoto, M | 1 |
1 review(s) available for moxalactam and Innate Inflammatory Response
Article | Year |
---|---|
Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Topics: Absorption; Adult; Aminoglycosides; Bacteria, Anaerobic; Central Nervous System Diseases; Child; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Female; Genital Diseases, Female; Humans; Infant, Newborn; Inflammation; Kidney Diseases; Kinetics; Male; Moxalactam; Respiratory Tract Infections; Sepsis; Staphylococcus; Streptococcus; Tissue Distribution; Urinary Tract Infections | 1983 |
1 trial(s) available for moxalactam and Innate Inflammatory Response
Article | Year |
---|---|
Imipenem versus moxalactam in the treatment of serious infections.
Topics: Adult; Aged; Bacterial Infections; Female; Humans; Imipenem; Inflammation; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Thienamycins | 1983 |
2 other study(ies) available for moxalactam and Innate Inflammatory Response
Article | Year |
---|---|
Evaluation of lamoxactam in the treatment of severe bacterial infections.
Topics: Abdomen; Adolescent; Adult; Aged; Bacterial Infections; Female; Humans; Inflammation; Male; Middle Aged; Moxalactam; Osteomyelitis; Phlebitis; Pneumonia; Sepsis; Surgical Wound Infection; Urinary Tract Infections | 1983 |
Penetration of intravenous antibiotics into brain abscesses.
Topics: Adult; Aged; Biomarkers; Brain Abscess; C-Reactive Protein; Cefotetan; Child; Combined Modality Therapy; Craniotomy; Empyema, Subdural; Female; Humans; Infant; Inflammation; Inhalation; Leukocyte Count; Male; Middle Aged; Moxalactam; Suppuration; Treatment Outcome | 1993 |